URO-MP- methenamine, sodium phosphate, monobasic, anhydrous, phenyl salicylate, methylene blue and hyoscyamine sulfate capsule

Страна: Соединенные Штаты

Язык: английский

Источник: NLM (National Library of Medicine)

Активный ингредиент:

METHENAMINE (UNII: J50OIX95QV) (METHENAMINE - UNII:J50OIX95QV), SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU) (SODIUM CATION - UNII:LYR4M0NH37), PHENYL SALICYLATE (UNII: 28A37T47QO) (PHENYL SALICYLATE - UNII:28A37T47QO), METHYLENE BLUE (UNII: T42P99266K) (METHYLENE BLUE CATION - UNII:ZMZ79891ZH), HYOSCYAMINE SULFATE (UNII: F2R8V82B84) (HYOSCYAMINE - UNII:PX44XO846X)

Доступна с:

Method Pharmaceuticals, LLC

ИНН (Международная Имя):

METHENAMINE

состав:

METHENAMINE 118 mg

Администрация маршрут:

ORAL

Тип рецепта:

PRESCRIPTION DRUG

Терапевтические показания :

Uro-MP Capsules are indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures. Uro-MP Capsules are contraindicated in patients with a hypersensitivity to any of the ingredients. Risk-benefit should be considered when the following medical problems exist: Cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

Обзор продуктов:

Uro-MP Capsules are blue capsules imprinted with 200, available in bottles of 100 capsules, (NDC: 58657-456-01).

Статус Авторизация:

unapproved drug other

Характеристики продукта

URO-MP- METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL
SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE CAPSULE
METHOD PHARMACEUTICALS, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
URO-MP CAPSULES
Rx Only
DESCRIPTION
Uro-MP Capsules for oral administration.
Each tablet contains:
Methenamine 118 mg
Sodium Phosphate Monobasic 40.8 mg
Phenyl Salicylate 36 mg
Methylene Blue 10 mg
Hyoscyamine Sulfate 0.12 mg
Inactive ingredients: Lactose, Polyethylene Glycol, Crospovidone,
Magnesium Stearate,
Colloidal Silicon Dioxide, FD&C Blue # 1, FD&C Red # 3, Titanium
Dioxide, Gelatin.
METHENAMINE. [100-97-0] 1,3,5,7-Tetraazatricyclo [3.3.1.-1
] decane;
hexamethylenetetramine; HMT; HMTA; hexamine; 1,3,5,7-
tetraazaadamantane hexamethylenemine; Uritone; Urotropin. C
H
N
; mol wt 140.19;
C 51.40%, H 8.63%, N 39.96%. Methenamine (hexamethylenetetramine)
exists as
colorless, lustrous crystals or white crystalline powder. Its
solutions are alkaline to
litmus. Freely soluble in water, soluble in alcohol and in chloroform.
SODIUM PHOSPHATE MONOBASIC. [7558-80-7] Phosphoric acid sodium salt
(1:1);
Sodium biphosphate; sodium dihydrogen phosphate; acid sodium
phosphate;
monosodium orthophosphate; primary sodium phosphate; H
NaO
P; mol wt 119.98, H
1.68%, Na 19.16%, O 53.34%, P 25.82%. Monohydrate, white, odorless
slightly
deliquesce crystals or granules. At 100° C loses all its water; when
ignited it converts to
metaphosphate. It is freely soluble in water and practically insoluble
in alcohol. The
aqueous solution is acid. pH of 0.1 molar aqueous solution at 25° C:
4.5.
PHENYL SALICYLATE. [118-55-8] 2-Hydroxybenzoic acid phenyl ester;
Salol. C
H
O
;
mol wt 214.22, C 72.89%, H 4.71%, O 22.41%. Made by the action of
phosphorus oxy-
chloride on a mixture of phenol and salicylic acid. Phenyl Salicylate
exists as white
crystals with a melting point of 41°-43° C. It is ve